Gross Profit Summary of Bionime Corporation

Bionime Corporation's latest annual gross profit in 2023 was 715.65 Million TWD , down -28.73% from previous year.
Bionime Corporation's latest quarterly gross profit in 2024 Q2 was 191.95 Million TWD , up 2.08% from previous quarter.
Bionime Corporation reported a annual gross profit of 1 Billion TWD in annual gross profit 2022, up 28.22% from previous year.
Bionime Corporation reported a annual gross profit of 783.13 Million TWD in annual gross profit 2021, up 4.54% from previous year.
Bionime Corporation reported a quarterly gross profit of 188.04 Million TWD for 2024 Q1, down -10.83% from previous quarter.
Bionime Corporation reported a quarterly gross profit of 160.44 Million TWD for 2023 Q3, down -6.42% from previous quarter.

Annual Gross Profit Chart of Bionime Corporation (2023 - 2009)

Historical Annual Gross Profit of Bionime Corporation (2023 - 2009)

Year	Gross Profit	Gross Profit Growth
2023	715.65 Million TWD	-28.73%
2022	1 Billion TWD	28.22%
2021	783.13 Million TWD	4.54%
2020	749.12 Million TWD	-21.01%
2019	948.41 Million TWD	3.43%
2018	916.99 Million TWD	15.23%
2017	795.77 Million TWD	3.28%
2016	770.48 Million TWD	9.87%
2015	701.29 Million TWD	17.94%
2014	594.62 Million TWD	-5.28%
2013	627.79 Million TWD	0.25%
2012	626.21 Million TWD	-11.95%
2011	711.23 Million TWD	18.98%
2010	597.78 Million TWD	31.59%
2009	454.28 Million TWD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	191.95 Million TWD	2.08%
2024 Q1	188.04 Million TWD	-10.83%
2023 Q3	160.44 Million TWD	-6.42%
2023 FY	715.65 Million TWD	-28.73%
2023 Q1	172.87 Million TWD	-43.09%
2023 Q4	210.89 Million TWD	31.44%
2023 Q2	171.44 Million TWD	-0.83%
2022 Q2	253.2 Million TWD	21.65%
2022 FY	1 Billion TWD	28.22%
2022 Q1	208.14 Million TWD	5.71%
2022 Q3	238.99 Million TWD	-5.61%
2022 Q4	303.78 Million TWD	27.11%
2021 Q4	196.9 Million TWD	-11.41%
2021 FY	783.13 Million TWD	4.54%
2021 Q1	203.7 Million TWD	-14.86%
2021 Q2	160.24 Million TWD	-21.33%
2021 Q3	222.27 Million TWD	38.71%
2020 Q1	150.61 Million TWD	-55.37%
2020 Q2	148.76 Million TWD	-1.23%
2020 Q3	210.48 Million TWD	41.48%
2020 FY	749.12 Million TWD	-21.01%
2020 Q4	239.26 Million TWD	13.68%
2019 FY	948.41 Million TWD	3.43%
2019 Q1	130.12 Million TWD	-58.3%
2019 Q2	255.66 Million TWD	96.48%
2019 Q3	225.14 Million TWD	-11.94%
2019 Q4	337.48 Million TWD	49.9%
2018 FY	916.99 Million TWD	15.23%
2018 Q4	312.06 Million TWD	28.1%
2018 Q3	243.61 Million TWD	19.1%
2018 Q2	204.54 Million TWD	30.47%
2018 Q1	156.77 Million TWD	-42.15%
2017 Q4	270.99 Million TWD	41.1%
2017 Q3	192.06 Million TWD	10.7%
2017 FY	795.77 Million TWD	3.28%
2017 Q2	173.5 Million TWD	8.98%
2017 Q1	159.21 Million TWD	-34.99%
2016 FY	770.48 Million TWD	9.87%
2016 Q4	244.9 Million TWD	22.05%
2016 Q3	200.66 Million TWD	6.48%
2016 Q2	188.44 Million TWD	38.09%
2016 Q1	136.46 Million TWD	-35.75%
2015 FY	701.29 Million TWD	17.94%
2015 Q3	194 Million TWD	34.23%
2015 Q4	212.39 Million TWD	9.48%
2015 Q2	144.53 Million TWD	-3.87%
2015 Q1	150.35 Million TWD	-20.85%
2014 Q4	189.95 Million TWD	38.34%
2014 Q1	124.34 Million TWD	-22.06%
2014 Q2	143.01 Million TWD	15.01%
2014 FY	594.62 Million TWD	-5.28%
2014 Q3	137.31 Million TWD	-3.99%
2013 Q3	159.03 Million TWD	-8.52%
2013 Q1	135.35 Million TWD	-4.07%
2013 FY	627.79 Million TWD	0.25%
2013 Q4	159.53 Million TWD	0.32%
2013 Q2	173.85 Million TWD	28.44%
2012 Q1	144.2 Million TWD	-29.62%
2012 Q4	141.09 Million TWD	-23.41%
2012 Q3	184.23 Million TWD	23.53%
2012 Q2	149.13 Million TWD	3.42%
2012 FY	626.21 Million TWD	-11.95%
2011 Q1	141.95 Million TWD	-18.48%
2011 FY	711.23 Million TWD	18.98%
2011 Q4	204.9 Million TWD	12.12%
2011 Q3	182.76 Million TWD	0.64%
2011 Q2	181.6 Million TWD	27.93%
2010 Q4	174.14 Million TWD	15.77%
2010 Q2	148.23 Million TWD	18.59%
2010 Q3	150.42 Million TWD	1.48%
2010 Q1	124.99 Million TWD	0.0%
2010 FY	597.78 Million TWD	31.59%
2009 FY	454.28 Million TWD	0.0%

Peer Gross Profit Comparison of Bionime Corporation

Name	Gross Profit	Gross Profit Difference
Nang Kuang Pharmaceutical Co., Ltd.	755.56 Million TWD	5.283%
Maxigen Biotech Inc.	424.09 Million TWD	-68.748%
SciVision Biotech Inc.	512.49 Million TWD	-39.641%
Pegavision Corporation	3.57 Billion TWD	79.96%
Visco Vision Inc.	857.15 Million TWD	16.509%

Global Stocks Search

Bionime Corporation (4737.TW)

Gross Profit Summary of Bionime Corporation

Annual Gross Profit Chart of Bionime Corporation (2023 - 2009)

Historical Annual Gross Profit of Bionime Corporation (2023 - 2009)

Peer Gross Profit Comparison of Bionime Corporation